Published by Frank Prenesti on 18th July 2023
(Sharecast News) - AstraZeneca and Sanofi's Beyfortus drug has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants, the two companies said on Tuesday.
URL: http://www.digitallook.com/dl/news/story/33644101/...